Fortuño, A. (., Bidegain, J. (., Robador, P. (. A., Hermida-Santos, J. (., Lopez-Sagaseta, J. (., Beloqui, O. (., . . . Zalba-Goñi, G. (. (2009). Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: Potential clinical implications in hypertension.
Citación estilo ChicagoFortuño, A. (Ana)|||/items/2324831f-71b3-4d1b-afc1-594e4e1bc0c9, J. (J.)|||/items/19022081-f59e-4202-9ed2-b056a4e4b584 Bidegain, P.A. (Pablo A.)|||/items/35b849ed-5afe-44ce-bd97-b7bf1ba0a307 Robador, J. (José)|||/items/9e67bdb3-d55d-4819-847e-9b44cc487fdb Hermida-Santos, J. (Jacinto)|||/items/ad7d0167-0d3c-4975-a77e-b64545be8010 Lopez-Sagaseta, O. (Óscar)|||/items/87d04a14-2d74-4221-8a57-12550777420d Beloqui, J. (Javier)|||/items/4f3a0e43-12bf-403d-9dc7-31fab0d11d41 Diez-Martinez, y G. (Guillermo)|||/items/71410fa2-baa5-4efc-bce7-14b4b0e23802 Zalba-Goñi. Losartan Metabolite EXP3179 Blocks NADPH Oxidase-mediated Superoxide Production By Inhibiting Protein Kinase C: Potential Clinical Implications in Hypertension. 2009.
Cita MLAFortuño, A. (Ana)|||/items/2324831f-71b3-4d1b-afc1-594e4e1bc0c9, et al. Losartan Metabolite EXP3179 Blocks NADPH Oxidase-mediated Superoxide Production By Inhibiting Protein Kinase C: Potential Clinical Implications in Hypertension. 2009.